Skip to main content

GSI S/V (Epclusa sofosbuvir 200 mg / velpatasvir 50 mg)

Generic Name: sofosbuvir/velpatasvir

Pill with imprint GSI S/V is Pink, Elliptical / Oval and has been identified as Epclusa sofosbuvir 200 mg / velpatasvir 50 mg. It is supplied by Gilead Sciences, Inc..

Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 200 mg / velpatasvir 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI S/V

Epclusa sofosbuvir 200 mg / velpatasvir 50 mg GSI S/V

Epclusa

Generic Name
sofosbuvir/velpatasvir
Imprint
GSI S/V
Strength
sofosbuvir 200 mg / velpatasvir 50 mg
Color
Pink
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-2203

Get help with Imprint Code FAQs.

Related Images for "GSI S/V"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.